The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...

Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, is pleased to announce the inclusion of the first patient in its phase I ...

A South Carolina native and two-time Super Bowl champion celebrated a life win recently. Jim Stuckey is cancer-free after an ...

The FDA granted regenerative medicine advanced therapy designation to iltamciocel for patients with oropharyngeal dysphagia ...

April is Head neck cancer awareness month. Head and neck cancers aren’t just random, they’re often tied to things you can be ...

Through an international joint research, a Korean research team developed the world's first pre-stage lesion (pre-cancer lesion) that implements the world's first pre-stage head and neck cancer lesion ...

Beth Riehle, a cancer patient, is using social media to show that life can still be full and meaningful, even after a ...

Researchers at the University of Kentucky have introduced a novel microscopy technique that could revolutionize cancer research by providing an ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...